Medicare Enrolled
Dr. Andrew Najovits, MD
Cardiovascular Disease · Suffern, NY
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Najovits from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Najovits?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Najovits
Dr. Andrew Najovits is a cardiovascular disease specialist in Suffern, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Najovits performed 4,599 Medicare services across 3,167 unique beneficiaries.
Between the years covered by Open Payments, Dr. Najovits received a total of $5,172 from 44 pharmaceutical and/or device companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Najovits is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 15% volume in NY
$5,172 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,599
Medicare services
Top 15% in NY for cardiovascular disease
3,167
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~287 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
997 | $12 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
946 | $104 | $369 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
544 | $174 | $713 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
448 | $7 | $23 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
376 | $45 | $194 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
210 | $97 | $316 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
194 | $72 | $214 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
189 | $72 | $253 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
162 | $113 | $400 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
122 | $60 | $243 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
106 | $415 | $1,669 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
80 | $135 | $557 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
72 | $94 | $545 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
39 | $3 | $62 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
33 | $22 | $92 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
22 | $12 | $53 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
19 | $100 | $511 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
14 | $24 | $81 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
13 | $21 | $144 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
13 | $16 | $79 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.1% high complexity
20.4% medium
67.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,172
Total received (2018-2024)
Avg $739/year across 7 years
Top 31% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
322
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,172 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$246
2023
$240
2022
$224
2021
$240
2020
$598
2019
$1,673
2018
$1,952
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$117
iRhythm Technologies, Inc.
$38
ATRICURE, INC.
$31
Medtronic, Inc.
$23
E.R. Squibb & Sons, L.L.C.
$23
Kiniksa Pharmaceuticals International, plc
$14
Top 3 companies account for 75.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$554
Janssen Pharmaceuticals, Inc
$482
E.R. Squibb & Sons, L.L.C.
$366
AstraZeneca Pharmaceuticals LP
$335
Amgen Inc.
$296
ATRICURE, INC.
$292
PFIZER INC.
$244
Lantheus Medical Imaging, Inc.
$204
AtriCure, Inc.
$194
Boston Scientific Corporation
$192
SANOFI-AVENTIS U.S. LLC
$174
Abbott Laboratories
$153
Edwards Lifesciences Corporation
$152
Gilead Sciences, Inc.
$149
Boehringer Ingelheim Pharmaceuticals, Inc.
$143
Kowa Pharmaceuticals America, Inc.
$106
BOSTON SCIENTIFIC CORPORATION
$100
Amarin Pharma Inc.
$98
Bardy Diagnostics, Inc.
$92
iRhythm Technologies, Inc.
$91
Regeneron Healthcare Solutions, Inc.
$90
Allergan Inc.
$84
Actelion Pharmaceuticals US, Inc.
$80
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$54
PORTOLA PHARMACEUTICALS, INC.
$43
Lundbeck LLC
$41
ARBOR PHARMACEUTICALS, INC.
$35
Cardiovascular Systems Inc.
$33
Preventice Services, LLC
$31
Esperion Therapeutics, Inc.
$31
G Medical Diagnostic Services, Inc.
$29
ARALEZ PHARMACEUTICALS US INC.
$29
Medtronic, Inc.
$23
Chiesi USA, Inc.
$17
Novo Nordisk Inc
$15
Kiniksa Pharmaceuticals International, plc
$14
Merck Sharp & Dohme Corporation
$14
Relypsa, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
Medtronic Vascular, Inc.
$13
Dynavax Technologies Corporation
$13
BIOTRONIK INC.
$12
ABIOMED
$12
Arbor Pharmaceuticals, Inc.
$11
Top 3 companies account for 27.1% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · ATRICLIP LAA EXCLUSION SYSTEM · Adempas · Arcalyst · AtriCure Synergy Ablation System · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · CLEVIPREX · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Circulatory Support · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DEFINITY · Definity · ELIQUIS · ENTRESTO · Edarbi · FARXIGA · HeartMate 3 Left Ventricular Dev · Heplisav-B · Impella · JARDIANCE · LEQVIO · LOKELMA · LifeVest · Livalo · MICRA · MULTAQ · NEXLETOL · NORTHERA · Ozempic · PERCLOSE PROSTYLE · PORTICO · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · RESONATE · Repatha · SAPIEN 3 Ultra RESILIA · SYNERGY ABLATION SYSTEM · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO Patch · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
586
Per 100K population
172.9
County median income
$110,631
Nearest hospital
GOOD SAMARITAN HOSPITAL OF SUFFERN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Najovits is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 15% in NY), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Najovits experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Najovits performed 997 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Najovits receive payments from pharmaceutical companies?
Yes. Dr. Najovits received a total of $5,172 from 44 companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Najovits's costs compare to other cardiologists in Suffern?
Dr. Najovits's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Najovits) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Suffern
Browse cardiologists in Suffern ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology